Article

Eversight, Department of Health – Abu Dhabi partner to establish UAE’s first eye and tissue bank

Author(s):

The partnership was formalized at the recent International Conference for Initiatives on Organ and Tissue Donation and Transplantation in Abu Dhabi.

The partnership was formalized at the recent International Conference for Initiatives on Organ and Tissue Donation and Transplantation in Abu Dhabi.

The partnership was formalized at the recent International Conference for Initiatives on Organ and Tissue Donation and Transplantation in Abu Dhabi.

Eversight and the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, are partnering to establish the first eye and tissue bank in the United Arab Emirates (UAE).

According to a news release, the partnership was formalized at the recent International Conference for Initiatives on Organ and Tissue Donation and Transplantation in Abu Dhabi.

“The establishment of the UAE’s first eye and tissue bank will provide a critical resource to the approximately one million people in the region who suffer from corneal blindness, including more than 12,000 people in the UAE,” said Erik Hellier, director of Global Development at Eversight. “We are excited to partner with the DoH on this project that is directly aligned with our goals of creating and restoring vision health around the world, and leveraging our expertise, cultural competence and philanthropic support to help the UAE develop its own eye banking infrastructure.”

Moreover, under terms of the agreement Eversight will handle the development and implementation of comprehensive medical standards, quality assurance protocols and standard operating procedures in compliance with all laws and regulations of the UAE and in accordance with eye banking best practices.

The DoH will be responsible for obtaining all necessary approvals for the establishment and operation of the eye and tissue bank, serving as an importer for corneas and other eye-related tissues into the region and working to integrate the eye/tissue banking program with the UAE National Program for Organ Donation.

This initiative will also strengthen mutual collaboration in activities related to knowledge sharing, human capability building and clinical research.

“Under the directives of our wise leadership, Abu Dhabi continues to partner with leading international bodies to elevate its national healthcare operations across all fronts,” said HE Dr. Jamal Mohammed Al Kaabi, Undersecretary of the Department of Health. “We are proud to partner with Eversight to establish yet another impactful program that contributes to maintaining and enhancing lives in the UAE and beyond. Through this partnership, we aim to further improve healthcare outcomes and facilitate quick and seamless operations for all patients in need of eye-tissue transplantation in the UAE.”

According to the news release, an estimated 2.2 billion people worldwide are impacted by blindness and visual impairment. Approximately one billion of these individuals are coping with blindness or visual impairment that can be characterized as preventable or not sufficiently addressed. This includes 12 million people who suffer from corneal blindness, making it the fourth leading cause of blindness globally. Eversight is working to address this global burden and help make vision a reality for more people worldwide. For more information about Eversight’s global vision, visit eversightvision.org/global.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.